• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝司他汀对小鼠P388白血病淋巴结转移的抑制作用。

Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.

作者信息

Tsuruo T, Naganuma K, Iida H, Yamori T, Tsukagoshi S, Sakurai Y

出版信息

J Antibiot (Tokyo). 1981 Sep;34(9):1206-9. doi: 10.7164/antibiotics.34.1206.

DOI:10.7164/antibiotics.34.1206
PMID:7328059
Abstract

Bestatin, a chemically defined immunostimulant of low molecular weight, suppressed the gradually-occurring lymph node metastasis of P388 leukemia in CDF1 mice when administered i.p. at the doses of 1 approximately 30 micrograms/mouse. It could not, however, suppress the established large metastasis of P388 leukemia. Lymph node cells isolated from the mice given bestatin i.p. at 1 and 30 microgram/mouse showed cytostatic activity against P388 leukemic cells in vitro than those from the untreated mice.

摘要

贝司他汀是一种化学结构明确的低分子量免疫刺激剂,当以1至30微克/小鼠的剂量腹腔注射给药时,可抑制CDF1小鼠中P388白血病逐渐发生的淋巴结转移。然而,它不能抑制已形成的P388白血病大转移灶。腹腔注射1微克/小鼠和30微克/小鼠贝司他汀的小鼠分离出的淋巴结细胞,与未处理小鼠的淋巴结细胞相比,在体外对P388白血病细胞表现出细胞抑制活性。

相似文献

1
Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.贝司他汀对小鼠P388白血病淋巴结转移的抑制作用。
J Antibiot (Tokyo). 1981 Sep;34(9):1206-9. doi: 10.7164/antibiotics.34.1206.
2
Lymph node metastasis and effects of 1-beta-D-arabinofuranosylcytosine, 5-fluorouracil, and their lipophilic derivatives in an experimental model system using P388 leukemia.在使用P388白血病的实验模型系统中,淋巴结转移以及1-β-D-阿拉伯呋喃糖基胞嘧啶、5-氟尿嘧啶及其亲脂性衍生物的作用。
Cancer Res. 1980 Dec;40(12):4758-63.
3
Antitumor activity of kijanimicin.
J Antibiot (Tokyo). 1983 Aug;36(8):1078-9. doi: 10.7164/antibiotics.36.1078.
4
Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.新型化疗药物BBM 928A的实验性抗肿瘤活性与毒性
Cancer Res. 1983 Apr;43(4):1504-10.
5
Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).对N-(膦酰基乙酰基)-L-天冬氨酸的 collateral 敏感性在一株对L-(αS,5S)-α-氨基-3-氯-4,5-二氢-5-异恶唑乙酸(阿西维辛)产生抗性的P388白血病细胞系中。 (注:“collateral”这里可能是专业术语“旁系的”之类意思,具体准确意思需结合专业知识进一步确定)
Cancer Res. 1983 Apr;43(4):1598-601.
6
Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
Gan. 1979 Aug;70(4):411-20.
7
Some structure-activity relationships for bactobolin analogs in the treatment of mouse leukemia P388.杆菌肽类似物治疗小鼠白血病P388的一些构效关系。
Chem Pharm Bull (Tokyo). 1981 Mar;29(3):891-4. doi: 10.1248/cpb.29.891.
8
Activity of a novel carotenoid analog, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaen -1,18- diyl) bis(1-ethylpyridinium) dibromide (Y-18598) on mouse leukemia P388.新型类胡萝卜素类似物4,4'-(3,7,12,16-四甲基-1,3,5,7,9,11,13,15,17-十八碳九烯-1,18-二基)双(1-乙基吡啶鎓)二溴化物(Y-18598)对小鼠白血病P388的活性
J Cancer Res Clin Oncol. 1985;109(3):257-9. doi: 10.1007/BF00390366.
9
The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases.脂质体包裹的阿霉素对淋巴结转移的抗肿瘤作用。
Jpn J Surg. 1990 Jul;20(4):424-8. doi: 10.1007/BF02470826.
10
Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.吡唑呋喃与5-氮杂胞苷联合对小鼠P388和L1210白血病及结肠癌26的抗肿瘤活性。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1857-62.

引用本文的文献

1
Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.多功能纳米颗粒递呈小干扰 RNA 和阿霉素克服癌症耐药性。
J Biol Chem. 2010 Jul 16;285(29):22639-50. doi: 10.1074/jbc.M110.125906. Epub 2010 May 11.
2
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.氨肽酶-N/CD13(EC 3.4.11.2)抑制剂:化学、生物学评价及治疗前景
Med Res Rev. 2006 Jan;26(1):88-130. doi: 10.1002/med.20044.
3
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.
氨肽酶N/CD13高表达增强人黑色素瘤的侵袭和转移
Clin Exp Metastasis. 1995 Sep;13(5):337-44. doi: 10.1007/BF00121910.
4
Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.贝司他汀的药代动力学及治疗实验性转移的口服活性
Cancer Immunol Immunother. 1989;28(1):29-33. doi: 10.1007/BF00205797.
5
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.环磷酰胺与贝司他汀联合化学免疫疗法对小鼠实验性转移的影响
Cancer Immunol Immunother. 1989;29(4):231-6. doi: 10.1007/BF00199209.
6
Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice.贝司他汀对正常及环磷酰胺处理小鼠骨髓造血干细胞的影响。
Cancer Immunol Immunother. 1990;32(2):75-80. doi: 10.1007/BF01754202.
7
Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme.氨肽酶N、A和W的抑制作用。对贝他汀和血管紧张素转换酶抑制剂作用的重新评估。
Biochem Pharmacol. 1992 Nov 3;44(9):1725-30. doi: 10.1016/0006-2952(92)90065-q.